Skip to main content
. 2003 Mar;41(3):1192–1202. doi: 10.1128/JCM.41.3.1192-1202.2003

TABLE 2.

Antibiotic susceptibilities of P. aeruginosa and S. aureus isolates recovered in the BWC from 1996 to 1998a

Organism and antibiotic Percentb
No. of isolates tested
R S I
P. aeruginosa
    Imipenem-cilastin 7.5 85 7.5 146
    Imipenem 16.7 74.5 8.8 317
    Amikacin 21.7 45.5 32.8 686
    Ceftazidime 21.9 75.9 2.2 686
    Meropenem 28.4 63.4 8.2 134
    Aztreonam 29.2 51.5 19.3 685
    Cefepime 48 38.6 13.4 171
    Piperacillin 67.3 32.7 0 688
    Cefsulodin 69.3 29.2 1.5 685
    Norfloxacin 71.2 27 1.8 685
    Ticarcillin 71.3 28.6 0.1 688
    Ciprofloxacin 95.9 2.7 1.4 73
S. aureus
    Vancomycin 0 100 0 12
    Netilmicin 0.6 98.9 0.6 544
    Minocycline 1.6 98.2 0.2 546
    Trimethoprim-sulfamethoxazole 4.7 94.7 0.5 551
    Oxacillin 17.5 82.5 0 553
    Amoxicillin-clavulanic acid 17.9 81.7 0.4 553
    Erythromycin 38.6 60.3 1.1 544
    Penicillin V 91.3 8.5 0.2 554
a

Determined by the Bauer-Kirby agar disk diffusion method.

b

R, resistant; S, sensitive; I, intermediate level of resistance.